IL-6 signalling has been shown to be an important pathway in RCC, by activating STAT3 which promotes tumorigenesis, inhibits apoptosis, and enhances proliferation, angiogenesis, invasiveness and immune evasion40. This evidence concerns the gene STAT3 and renal cell carcinoma.